title: Medicare home infusion therapy reimbursement gap.
abstract: This research seeks to address the home infusion therapy reimbursement gap found within Medicare Part D. In particular, the research explored the reimbursement gap's impact on home health utilization, its contribution to the national health expenditure growth, and the potential fix of the problem by restructuring Medicare Part B to include a home infusion therapy benefit under its coverage. Previous studies found that there is a great cost avoidance opportunity available through home health and home infusion treatment, because such treatment avoids the high costs associated with hospitalization and nursing home and other long-term care facilities. Future implications of this topic are unclear, as the Affordable Health Care for America Act is equipped to cut Medicare services and reimbursements, in spite of current bipartisan legislation in both houses to cover the home infusion reimbursement gap.
authors.affiliation: CarePoint Partners of West Virginia, LLC, Charleston, WV 25303, USA.
authors.forename: Joshua
authors.initials: J
authors.lastname: Webb
authors.forename: Doohee
authors.initials: D
authors.lastname: Lee
mesh_terms: D003363:Cost Control; D005102:Health Expenditures / Q000639:trends; D006699:Home Care Services; D018718:Home Infusion Therapy / Q000191:economics*; D006801:Humans; D007342:Insurance Benefits; D054524:Medicare Part D; D012051:Reimbursement Mechanisms; D014481:United States